Tvardi Therapeutics, Inc. Common Stock (TVRD)

Tvardi Therapeutics, Inc. is a biotechnology company focused on developing targeted therapies for inflammatory and fibrotic diseases. The company leverages its proprietary drug discovery platform to identify and advance small-molecule treatments aimed at challenging conditions, with an emphasis on improving patient outcomes.